View in EDS

The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.

Saved in:
Bibliographic Details
Title: The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.
Authors: Zielli T; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland., Labidi-Galy I; Department of Oncology, Geneva University Hospitals, Geneva 1205, Switzerland.; Department of Medicine, Center of Translational Research in Onco-Hematology, Geneva 1205, Switzerland., Del Grande M; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland., Sessa C; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland., Colombo I; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland.
Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2023 Jul 28; Vol. 6 (3), pp. 499-516. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37842243
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zielli+T%22">Zielli T</searchLink>; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+I%22">Labidi-Galy I</searchLink>; Department of Oncology, Geneva University Hospitals, Geneva 1205, Switzerland.; Department of Medicine, Center of Translational Research in Onco-Hematology, Geneva 1205, Switzerland.<br /><searchLink fieldCode="AU" term="%22Del+Grande+M%22">Del Grande M</searchLink>; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sessa+C%22">Sessa C</searchLink>; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland.<br /><searchLink fieldCode="AU" term="%22Colombo+I%22">Colombo I</searchLink>; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101738710%22">Cancer drug resistance (Alhambra, Calif.)</searchLink> [Cancer Drug Resist] 2023 Jul 28; Vol. 6 (3), pp. 499-516. <i>Date of Electronic Publication: </i>2023 Jul 28 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22OAE+Publishing+Inc%22">OAE Publishing Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101738710 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2578-532X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222578532X%22">2578532X </searchLink><i>NLM ISO Abbreviation: </i>Cancer Drug Resist <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37842243
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.20517/cdr.2023.08
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 499
    Titles:
      – TitleFull: The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zielli T
      – PersonEntity:
          Name:
            NameFull: Labidi-Galy I
      – PersonEntity:
          Name:
            NameFull: Del Grande M
      – PersonEntity:
          Name:
            NameFull: Sessa C
      – PersonEntity:
          Name:
            NameFull: Colombo I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 07
              Text: 2023 Jul 28
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2578-532X
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cancer drug resistance (Alhambra, Calif.)
              Type: main
ResultId 1